Articles

Home /Articles / FDA Federal Register Notices

No article fund in this category

Top News

Report says Makary May Face Ouster Amid White House Tensions
Advertising Experts Critique FDAs Increasing Enforcement
CBER Acting Head Highlights Regulatory Flexibility, AI and Rare Disease Priorities
Sanofi Seeks Removal of Tzield From FDA Priority Review Program
New CDER Biologics Compliance Program Explained
Brookings Economist Backs FDA Biosimilar Draft Guide
House Committee Would Limit Foreign Trial Data
10 Observations in Somerset Therapeutics FDA-483

Prev

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Dickinson's FDA Webview is the interactive Web site that watches the U.S. Food and Drug Administration all day long. From the leading publisher of FDA-content business newsletters since 1984, you can monitor regulatory, legal, policy and scientific news affecting all FDA-regulated healthcare products and their marketing activities.